The TASTY-steering Study

Recruiting N/A Interventional Study
Metastatic Triple Negative Breast Cancer Metastatic Testicular Cancer Stage II-IV Diffuse Large B Cell Lymphoma
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 70
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
201 (estimated)
Sponsor
University Medical Center Groningen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This is a multicentre non-blinded randomised intervention trial with a parallel cluster design. The multicentre study will be performed at 12 hospitals in the Netherlands. A parallel cluster design per hospital was selected to prevent contact between participants in the same hospital who are randomised into different study arms. Such contact may result in bias as it may allow for patients in the c…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥18 and ≤70 years * Indication to start chemotherapy for: * Metastatic triple negative breast cancer * Metastatic testicular cancer * Stage II-IV diffuse large B cell lymphoma * Chemotherapy scheduled to start in the next 6 weeks * Consuming solid foods and drinks i…
Contacts

J. J. de Haan, MD, PhD

+31 50 361 2821

j.j.de.haan@umcg.nl

CONTACT

M. D. Douma

+31 50 361 4603

m.d.douma@umcg.nl

CONTACT